Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer

Chemotherapy has been reported to increase the proportion of cancer stem cells (CSCs) and to promote epithelial-mesenchymal transition (EMT) phenotype changes. Anti-HER2 therapy may provide a strategy for eliminating CSC and EMT, which contribute to therapeutic resistance. No study has determined th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Teruo, Espinosa Fernandez, Jose Rodrigo, Imamura, Chiyo K., Yamauchi, Hideko, Jinno, Hiromitsu, Takahashi, Maiko, Kitagawa, Yuko, Nakamura, Seigo, Lim, Bora, Krishnamurthy, Savitri, Reuben, James M., Liu, Diane, Tripathy, Debasish, Chen, Helen, Takebe, Naoko, Saya, Hideyuki, Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805522/
https://www.ncbi.nlm.nih.gov/pubmed/29467936
http://dx.doi.org/10.18632/oncotarget.23914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805522/
https://www.ncbi.nlm.nih.gov/pubmed/29467936
http://dx.doi.org/10.18632/oncotarget.23914

Ejemplares similares